Dimethylfumarat-Mepha Teva 240 mg, magensaftresistente Hartkapseln

7680695040029 CH-69504 Magensaftresistente Hartkapseln

Associated product:

DIMETHYLFUMARAT Mepha Teva caps 240 mg 56 pce
Dimethylfumarat-Mepha Teva 240 mg, magensaftresistente Hartkapseln
Dimethylfumarat-Mepha Teva 240 mg, magensaftresistente Hartkapseln
Dimethylfumarat-Mepha Teva 240 mg, magensaftresistente Hartkapseln
1 / 3
google

Article details

Package size
56
Selling units
56
Measure
Kapsel(n)
Galenic form
Magensaftresistente Hartkapseln
Galenic group
Gastrointenstinales Therapiesystem

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/07/2025
Patient information leaflet
Français
09/07/2025
Patient information leaflet
Italien
09/07/2025
Summary of Product Characteristics
Allemand
09/07/2025
Summary of Product Characteristics
Français
09/07/2025
Summary of Product Characteristics
Italien
09/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
240.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 403.05
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2024

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
69504
Drug name
Dimethylfumarat-Mepha Teva, magensaftresistente Hartkapseln
Galenic form
KAHAM
ATC Code
L04AX07
Authorization status
Z
Dispensing category
B
First authorization
08/08/2024
Authorization expiration date
07/08/2029
IT Number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose

Package details

Description (FR)
DIMETHYLFUMARAT Mepha Teva caps 240 mg 56 pce
Description (DE)
DIMETHYLFUMARAT Mepha Teva Kaps 240 mg 56 Stk
Market launch
08/08/2024
Narcotic (BTM)
No

Original drug

Tecfidera, magensaftresistente Hartkapseln
GTIN: 7680628310014
CHF 287.50
View original

Other package sizes (2)

DIMETHYLFUMARAT Mepha Teva caps 120 mg 14 pce
14 KAP
GTIN: 7680695040012
View
DIMETHYLFUMARAT Mepha Teva caps 240 mg 168 pce
168 KAP
GTIN: 7680695040036
View